Home › Crohn's Disease › Kansas › Topeka
Crohn's Disease clinical trials in Topeka, KS
5 studies for Crohn's Disease are looking for participants at sites in and around Topeka (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- University of Kansas Health System Saint Francis Campus, Topeka
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
RecruitingPhase 3
- Cotton O'Neil Digestive Health Center ( Site 5033), Topeka
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
RecruitingPhase 2
- Cotton O'Neil Digestive Health Center, Topeka
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
RecruitingPhase 2
- Cotton O'Neil Digestive Health Center, Topeka
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
RecruitingPhase 3
- Cotton-O'Neil Clinical Research Center, Topeka
About Crohn's Disease
Crohn's Disease can cause inflammation in any area from the mouth to the anus. Read about medicines, surgery or dietary management to treat symptoms.
More about Crohn's Disease on MedlinePlus
Crohn's Disease trials in other cities
- New York City, NY33 studies
- St. Louis, MO19 studies
- Miami, FL19 studies
- Orlando, FL19 studies
- Boston, MA18 studies
- Houston, TX17 studies
- Atlanta, GA16 studies
- Tyler, TX16 studies
- San Diego, CA15 studies
- Cleveland, OH15 studies
- Colorado Springs, CO14 studies
- San Antonio, TX14 studies
Other studies in Topeka
- Steatotic Liver Disease8 studies
- Prostate Cancer7 studies
- Non-Small Cell Lung Cancer7 studies
- Type 2 Diabetes6 studies
- Breast Cancer6 studies
- Overweight6 studies
- Lung Cancer6 studies
- Obesity5 studies
- Bladder Cancer4 studies
- Melanoma4 studies
- Esophageal Cancer4 studies
- Cardiovascular Disease4 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.